These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 12898287
1. Association of late-onset Alzheimer disease with a genotype of PLAU, the gene encoding urokinase-type plasminogen activator on chromosome 10q22.2. Finckh U, van Hadeln K, Müller-Thomsen T, Alberici A, Binetti G, Hock C, Nitsch RM, Stoppe G, Reiss J, Gal A. Neurogenetics; 2003 Aug; 4(4):213-7. PubMed ID: 12898287 [Abstract] [Full Text] [Related]
2. Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene. Ertekin-Taner N, Ronald J, Feuk L, Prince J, Tucker M, Younkin L, Hella M, Jain S, Hackett A, Scanlin L, Kelly J, Kihiko-Ehman M, Neltner M, Hersh L, Kindy M, Markesbery W, Hutton M, de Andrade M, Petersen RC, Graff-Radford N, Estus S, Brookes AJ, Younkin SG. Hum Mol Genet; 2005 Feb 01; 14(3):447-60. PubMed ID: 15615772 [Abstract] [Full Text] [Related]
3. A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease. Riemenschneider M, Konta L, Friedrich P, Schwarz S, Taddei K, Neff F, Padovani A, Kölsch H, Laws SM, Klopp N, Bickeböller H, Wagenpfeil S, Mueller JC, Rosenberger A, Diehl-Schmid J, Archetti S, Lautenschlager N, Borroni B, Müller U, Illig T, Heun R, Egensperger R, Schlegel J, Förstl H, Martins RN, Kurz A. Hum Mol Genet; 2006 Aug 15; 15(16):2446-56. PubMed ID: 16825285 [Abstract] [Full Text] [Related]
4. The urokinase-type plasminogen activator polymorphism PLAU_1 is a risk factor for APOE-epsilon4 non-carriers in the Italian Alzheimer's disease population and does not affect the plasma Abeta(1-42) level. Pesaresi M, Batelli S, Prato F, Polito L, Lovati C, Scarpini E, Quadri P, Mariani C, Albani D, Forloni G. Neurobiol Dis; 2007 Mar 15; 25(3):609-13. PubMed ID: 17174555 [Abstract] [Full Text] [Related]
5. Variation in the urokinase-plasminogen activator gene does not explain the chromosome 10 linkage signal for late onset AD. Myers AJ, Marshall H, Holmans P, Compton D, Crook RJ, Mander AP, Nowotny P, Smemo S, Dunstan M, Jehu L, Wang JC, Hamshere M, Morris JC, Norton J, Chakraventy S, Tunstall N, Lovestone S, Petersen R, O'Donovan M, Jones L, Williams J, Owen MJ, Hardy J, Goate A. Am J Med Genet B Neuropsychiatr Genet; 2004 Jan 01; 124B(1):29-37. PubMed ID: 14681909 [Abstract] [Full Text] [Related]
7. No association of a non-synonymous PLAU polymorphism with Alzheimer's disease and disease-related traits. Papassotiropoulos A, Tsolaki M, Wollmer MA, Molyva D, Thal DR, Huynh KD, Tracy J, Staehelin HB, Monsch AU, Nitsch RM, Hock C. Am J Med Genet B Neuropsychiatr Genet; 2005 Jan 05; 132B(1):21-3. PubMed ID: 15558716 [Abstract] [Full Text] [Related]
8. Association study between Alzheimer's disease and genes involved in Abeta biosynthesis, aggregation and degradation: suggestive results with BACE1. Clarimón J, Bertranpetit J, Calafell F, Boada M, Tàrraga L, Comas D. J Neurol; 2003 Aug 05; 250(8):956-61. PubMed ID: 12928915 [Abstract] [Full Text] [Related]
9. The PLAU P141L single nucleotide polymorphism is associated with collateral circulation in patients with coronary artery disease. Duran J, Sánchez-Olavarría P, Mola M, Götzens V, Carballo J, Martín-Pelegrina E, Petit M, García Del Blanco B, García-Dorado D, de Anta JM. Rev Esp Cardiol (Engl Ed); 2014 Jul 05; 67(7):552-7. PubMed ID: 24952395 [Abstract] [Full Text] [Related]
11. Association of tagSNPs in the urokinase-plasminogen activator (PLAU) gene with Alzheimer's disease and associated quantitative traits. Ozturk A, Minster RL, DeKosky ST, Kamboh MI. Am J Med Genet B Neuropsychiatr Genet; 2007 Jan 05; 144B(1):79-82. PubMed ID: 16967469 [Abstract] [Full Text] [Related]
12. Urokinase-type plasminogen activator inhibits amyloid-beta neurotoxicity and fibrillogenesis via plasminogen. Tucker HM, Kihiko-Ehmann M, Estus S. J Neurosci Res; 2002 Oct 15; 70(2):249-55. PubMed ID: 12271474 [Abstract] [Full Text] [Related]
13. Association of putative functional variants in the PLAU gene and the PLAUR gene with myocardial infarction. Xu J, Li W, Bao X, Ding H, Chen J, Zhang W, Sun K, Wang J, Wang X, Wang H, Yu H, Song W, Ma W, Zhang L, Wang C, Wang D, Hui R. Clin Sci (Lond); 2010 Jul 09; 119(8):353-9. PubMed ID: 20518747 [Abstract] [Full Text] [Related]
14. Meta-analysis of the association between urokinase-plasminogen activator gene rs2227564 polymorphism and Alzheimer's disease. Wu W, Jiang H, Wang M, Zhang D. Am J Alzheimers Dis Other Demen; 2013 Aug 09; 28(5):517-23. PubMed ID: 23813610 [Abstract] [Full Text] [Related]
18. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN. Am J Pathol; 1996 Jun 09; 148(6):2083-95. PubMed ID: 8669492 [Abstract] [Full Text] [Related]
19. Gene Association Study of the Urokinase Plasminogen Activator and Its Receptor Gene in Alzheimer's Disease. Cetinsoy O, Anyanwu I, Krishnanand H, Natarajan G, Ramachandran N, Thomas A, Brookes KJ. J Alzheimers Dis; 2024 Jun 09; 99(1):241-250. PubMed ID: 38669542 [Abstract] [Full Text] [Related]
20. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease. Cui T, Zhou X, Jin W, Zheng F, Cao X. Chin Med J (Engl); 2000 Apr 09; 113(4):340-4. PubMed ID: 11775232 [Abstract] [Full Text] [Related] Page: [Next] [New Search]